Vineet Laboratories Limited (BOM:543298)

Market Cap	753.08M +159.5%
Revenue (ttm)	560.13M -43.4%
Net Income	-101.39M
EPS	-11.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	77,615
Average Volume	8,176
Open	42.99
Previous Close	36.27
Day's Range	37.00 - 43.52
52-Week Range	25.35 - 51.84
Beta	n/a
RSI	78.61
Earnings Date	May 12, 2026

About Vineet Laboratories

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl th...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2016
• Employees: 57
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543298